ARCHIVES

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

This article is from The Cancer Letter archive.

Vol. 40 No. 44 | November 21, 2014

Download PDF Visit The Full Archive

Related Articles

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

Screening Concepts For Minority Women and Hispanics Approved

May 26, 1989

ONS Continue Growth, Associate Category Defeated Again

May 15, 1987

1.7% Cut Expected in NCI Budget Under Deficit Agreement

November 24, 1989

Breast Cancer Progress Report Summaries

November 14, 1975